NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner

Hui Li,Tian Lan,Lin Xu,Hailing Liu,Jinju Wang,Jiaxin Li,Xiangzheng Chen,Jiwei Huang,Xuefeng Li,Kefei Yuan,Yong Zeng,Hong Wu

DOI: https://doi.org/10.1186/s13046-020-01638-3

2020-07-06

Abstract:Hepatocellular carcinoma is the third top cause of cancer-related mortalities worldwide. The prognosis of HCC patients remains poor due to rapid progression and high incidence of tumor recurrence. Nicastrin (NCSTN), a core subunit of γ-Secretase, has been reported to play a vital role in tumor progression. However, no study till now has revealed its role in HCC.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of Nicastrin (NCSTN) in hepatocellular carcinoma (HCC) and its underlying mechanisms. Specifically, the research aims to:

1. **Evaluate the expression level of NCSTN in HCC**: Detect the expression differences of NCSTN in HCC tissues and normal liver tissues by methods such as immunohistochemical staining, Western blot and quantitative real - time PCR.

2. **Analyze the relationship between NCSTN and the prognosis of HCC patients**: Explore the relationship between the expression level of NCSTN and the overall survival rate and recurrence - free survival rate of HCC patients through survival analysis.

3. **Study the influence of NCSTN on the growth and metastasis of HCC cells**: Evaluate the influence of NCSTN on the proliferation, migration and invasion abilities of HCC cells by using in vitro experiments (such as CCK - 8, colony formation, cell cycle, scratch healing, Transwell migration and invasion experiments) and in vivo experiments (such as xenograft tumor models).

4. **Reveal the molecular mechanism by which NCSTN promotes HCC progression**: Through mechanism research, it is found that NCSTN induces epithelial - mesenchymal transition (EMT) by activating the β - catenin signaling pathway and depending on the Notch1 and AKT signaling pathways, thereby promoting the growth and metastasis of HCC cells.

In summary, the main objective of this study is to clarify the role of NCSTN in HCC and its underlying molecular mechanisms, and to provide a theoretical basis for further development of diagnostic markers and therapeutic targets for HCC.